B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter

Summary Company Announcement Date: August 19, 2026 FDA Publish Date: August 19, 2026 Product Type: Drugs Reason for Announcement: Recall Reason Description Presence of particulate matter identified primarily as cellulose cotton fibers, with individual particles also identified as cellulose wood fiber and polystyrene Company Name: (B. Braun) Brand Name: Brand Name(s) Product Description: Product Description…

Early Alert: Convenience Kit Issue from Becton Dickinson

 CDRH is issuing this Early Alert to notify the public of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available.   Affected Product The FDA is aware that Becton Dickinson (BD) has issued a letter to affected customers recommending certain convenience…

Breathing Circuit Set Recall: Hamilton Medical Removes Breathing Circuit Set

The recommendations provided below have changed. This recall involves removing certain devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it. Affected Product The FDA is aware that Hamilton Medical has issued…

Update on Alert: Convenience Kit Issue from Medline

CDRH is issuing this Early Alert to notify the public of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available. Affected lots have been added to the Excel sheet in the Affected Product section. Affected Product The FDA is aware that…

Intravascular Administration Set Recall: Baxter Removes Duo-Vent Solution Sets

This recall involves removing certain devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it. The affected products and recommendations for what to do with the devices below have not changed. Affected…

Fresenius Kabi Issues Nationwide Recall of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL Vials Due to Presence of Glass Particles

Summary Company Announcement Date: August 10, 2026 FDA Publish Date: August 11, 2026 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to Presence of Glass Particles Company Name: Fresenius Kabi Brand Name: Brand Name(s) Fresenius Kabi Product Description: Product Description Tyenne Injection 400 mg/20 mL vial Company Announcement August 10, 2026 – LAKE…